搜索





搜索





市场行情
/
股票
/
spro
/

Spero Therapeutics Inc

SPRO

添加自选

1.195USD

+0.015+1.27%

收盘 07-28 16:00（美东）报价延迟15分钟

69.18M总市值

4.30市盈率 TTM

Spero Therapeutics Inc

1.195

+0.015+1.27%

概览

财务

分析

公司

财务摘要利润表资产负债表现金流量表

SPRO 利润表

您可以在这里找到Spero Therapeutics Inc的年度或季度收入报告，以深入了解Spero Therapeutics Inc的运营、管理效率和表现。

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

FY2016Q4

FY2016Q3

营业总收入

-95.61%258.00K

174.51%41.30M

-59.60%5.44M

39.15%14.19M

-36.61%5.87M

-79.54%15.04M

-47.12%13.47M

275.44%10.20M

347.90%9.27M

54.98%73.52M

1169.84%25.47M

36.28%2.72M

0.00%2.07M

1628.90%47.44M

-34.53%2.01M

-61.29%1.99M

-71.66%2.07M

43.89%2.74M

-23.30%3.06M

198.09%5.15M

329.16%7.30M

-47.47%1.91M

-13.96%4.00M

-19.90%1.73M

-77.96%1.70M

114.54%3.63M

605.62%4.64M

365.66%2.16M

569.38%7.72M

70.39%1.69M

10.22%658.00K

85.94%463.00K

723.57%1.15M

196.42%993.00K

--597.00K

--249.00K

--140.00K

--335.00K

--0.00

营业收入

-95.61%258.00K

174.51%41.30M

-59.60%5.44M

39.15%14.19M

-36.61%5.87M

-79.54%15.04M

-47.12%13.47M

275.44%10.20M

347.90%9.27M

54.98%73.52M

1169.84%25.47M

36.28%2.72M

0.00%2.07M

1628.90%47.44M

-34.53%2.01M

-61.29%1.99M

-71.66%2.07M

43.89%2.74M

-23.30%3.06M

198.09%5.15M

329.16%7.30M

-47.47%1.91M

-13.96%4.00M

-19.90%1.73M

-77.96%1.70M

114.54%3.63M

605.62%4.64M

365.66%2.16M

569.38%7.72M

70.39%1.69M

10.22%658.00K

85.94%463.00K

723.57%1.15M

196.42%993.00K

--597.00K

--249.00K

--140.00K

--335.00K

--0.00

营业费用

-61.84%7.80M

-72.44%9.89M

-60.17%12.77M

-43.43%16.55M

-12.13%20.43M

56.12%35.89M

45.07%32.06M

87.48%29.26M

42.67%23.25M

6.51%22.99M

57.95%22.10M

-3.81%15.61M

-49.51%16.30M

-28.64%21.58M

-45.32%13.99M

-31.52%16.22M

20.87%32.28M

46.09%30.25M

11.18%25.59M

17.26%23.69M

8.89%26.70M

-29.85%20.70M

1.71%23.02M

27.80%20.20M

82.81%24.52M

131.00%29.51M

95.19%22.63M

51.50%15.81M

12.07%13.41M

-14.79%12.78M

9.75%11.59M

0.19%10.43M

54.66%11.97M

63.95%14.99M

33.47%10.56M

--10.41M

--7.74M

--9.14M

--7.91M

研发费用

-78.62%2.91M

-80.61%5.59M

-68.00%8.60M

-55.02%10.67M

-21.50%13.61M

74.16%28.84M

63.87%26.86M

149.47%23.73M

93.03%17.33M

9.73%16.56M

122.73%16.39M

16.36%9.51M

-47.09%8.98M

-12.40%15.09M

-49.02%7.36M

-43.48%8.17M

-7.79%16.97M

30.44%17.23M

-18.47%14.44M

-7.63%14.46M

-9.94%18.40M

-48.67%13.21M

-4.27%17.71M

30.18%15.66M

114.53%20.44M

181.89%25.73M

118.64%18.50M

63.09%12.03M

6.73%9.53M

-27.00%9.13M

22.42%8.46M

-1.11%7.37M

48.77%8.93M

80.50%12.50M

15.07%6.91M

--7.46M

--6.00M

--6.93M

--6.00M

折旧摊销及损耗

----

-100.00%0.00

-98.15%2.00K

-100.00%0.00

-44.96%71.00K

-57.98%108.00K

-63.27%108.00K

-40.21%113.00K

-32.46%129.00K

73.65%257.00K

98.65%294.00K

18.87%189.00K

0.00%191.00K

-22.51%148.00K

-22.11%148.00K

-15.87%159.00K

--191.00K

-60.94%191.00K

1.06%190.00K

2.72%189.00K

----

503.70%489.00K

100.00%188.00K

93.68%184.00K

40.40%139.00K

-13.83%81.00K

13.25%94.00K

9.20%95.00K

16.47%99.00K

27.03%94.00K

--83.00K

--87.00K

--85.00K

--74.00K

营业利润

48.21%-7.54M

250.64%31.41M

60.58%-7.33M

87.61%-2.36M

-4.11%-14.56M

-141.26%-20.85M

-651.39%-18.59M

-47.87%-19.06M

1.72%-13.98M

95.43%50.53M

128.13%3.37M

9.42%-12.89M

52.90%-14.23M

194.02%25.86M

46.79%-11.99M

23.25%-14.23M

-55.68%-30.21M

-46.32%-27.50M

-18.42%-22.52M

-0.36%-18.54M

14.98%-19.40M

27.38%-18.80M

-5.75%-19.02M

-35.34%-18.48M

-300.65%-22.82M

-133.52%-25.88M

-64.47%-17.98M

-36.92%-13.65M

47.34%-5.70M

20.83%-11.08M

-9.72%-10.94M

1.91%-9.97M

-42.33%-10.82M

-58.91%-14.00M

-25.93%-9.97M

---10.16M

---7.60M

---8.81M

---7.91M

净非营业利息收入（费用）

利息收入

-61.11%336.00K

-63.42%376.00K

-54.99%532.00K

-38.23%740.00K

-34.89%864.00K

-1.44%1.03M

24.42%1.18M

22.00%1.20M

37.80%1.33M

45.87%1.04M

356.73%950.00K

784.68%982.00K

1237.50%963.00K

840.79%715.00K

131.11%208.00K

35.37%111.00K

-26.53%72.00K

55.10%76.00K

210.34%90.00K

-4.65%82.00K

-58.65%98.00K

-96.31%49.00K

--29.00K

--86.00K

--237.00K

--1.33M

----

利息费用

----

--0.00

-100.00%0.00

--0.00

--117.00K

--2.49M

--1.94M

----

特殊收入（费用）

100.00%0.00

---587.00K

---83.00K

---175.00K

---877.00K

100.00%0.00

----

-100.00%0.00

-4311.11%-5.31M

100.00%0.00

1.96%208.00K

--126.00K

---14.44M

---193.00K

--204.00K

----

-100.00%0.00

----

--223.00K

----

100.00%0.00

-100.00%0.00

-100.97%-6.00K

50.00%-2.00K

--350.00K

--1.20M

--617.00K

---4.00K

其他非经营性收入（费用）

-200.00%-1.00K

-100.00%0.00

107.69%2.00K

300.00%4.00K

107.14%1.00K

3200.00%99.00K

-160.00%-26.00K

116.67%1.00K

-600.00%-14.00K

133.33%3.00K

56.52%-10.00K

40.00%-6.00K

84.62%-2.00K

88.46%-9.00K

73.56%-23.00K

91.07%-10.00K

88.98%-13.00K

-148.15%-78.00K

-258.18%-87.00K

-112.60%-112.00K

82.49%-118.00K

124.77%162.00K

-79.48%55.00K

77.09%889.00K

-208.01%-674.00K

-234.85%-654.00K

-43.22%268.00K

3246.67%502.00K

262.79%624.00K

251.45%485.00K

280.65%472.00K

-71.15%15.00K

1663.64%172.00K

3550.00%138.00K

--124.00K

--52.00K

---11.00K

---4.00K

--0.00

税前利润

48.05%-7.20M

254.29%31.78M

57.66%-7.38M

90.48%-1.70M

-9.45%-13.87M

-139.94%-20.60M

-1654.23%-17.44M

-49.92%-17.86M

4.50%-12.67M

92.66%51.58M

91.49%-994.00K

58.46%-11.91M

59.59%-13.27M

191.56%26.77M

48.16%-11.68M

-54.44%-28.68M

-69.02%-32.83M

-57.33%-29.24M

-18.93%-22.52M

-6.12%-18.57M

16.49%-19.42M

25.62%-18.59M

-6.88%-18.94M

-33.09%-17.50M

-358.56%-23.26M

-135.74%-24.99M

-69.33%-17.72M

-32.08%-13.15M

52.35%-5.07M

23.57%-10.60M

-6.29%-10.46M

-1.98%-9.96M

-66.03%-10.64M

-69.18%-13.87M

-24.32%-9.84M

---9.76M

---6.41M

---8.20M

---7.92M

所得税

----

-10.00%261.00K

100.00%0.00

----

-25.06%290.00K

-113.12%-290.00K

----

--387.00K

--2.21M

----

--0.00

----

--0.00

----

除税后利润

48.05%-7.20M

250.90%31.52M

56.95%-7.38M

90.48%-1.70M

-9.45%-13.87M

-140.80%-20.89M

-435.01%-17.15M

-49.92%-17.86M

4.50%-12.67M

91.22%51.19M

72.55%-3.21M

58.46%-11.91M

59.59%-13.27M

191.56%26.77M

48.16%-11.68M

-54.44%-28.68M

-69.02%-32.83M

-57.33%-29.24M

-18.93%-22.52M

-6.12%-18.57M

16.49%-19.42M

25.62%-18.59M

-6.88%-18.94M

-33.09%-17.50M

-358.56%-23.26M

-135.74%-24.99M

-69.33%-17.72M

-32.08%-13.15M

52.35%-5.07M

23.57%-10.60M

-6.29%-10.46M

-1.98%-9.96M

-66.03%-10.64M

-69.18%-13.87M

-24.32%-9.84M

---9.76M

---6.41M

---8.20M

---7.92M

持续经营利润

48.05%-7.20M

250.90%31.52M

56.95%-7.38M

90.48%-1.70M

-9.45%-13.87M

-140.80%-20.89M

-435.01%-17.15M

-49.92%-17.86M

4.50%-12.67M

91.22%51.19M

72.55%-3.21M

58.46%-11.91M

59.59%-13.27M

191.56%26.77M

48.16%-11.68M

-54.44%-28.68M

-69.02%-32.83M

-57.33%-29.24M

-18.93%-22.52M

-6.12%-18.57M

16.49%-19.42M

25.62%-18.59M

-6.88%-18.94M

-33.09%-17.50M

-358.56%-23.26M

-135.74%-24.99M

-69.33%-17.72M

-32.08%-13.15M

52.35%-5.07M

23.57%-10.60M

-6.29%-10.46M

-1.98%-9.96M

-66.03%-10.64M

-69.18%-13.87M

-24.32%-9.84M

---9.76M

---6.41M

---8.20M

---7.92M

反常净利润

----

--0.00

----

--0.00

----

归属少数股东的净利润

----

100.00%0.00

99.39%-6.00K

99.50%-8.00K

---594.00K

---535.00K

---986.00K

---1.60M

归属于母公司的净利润

48.05%-7.20M

250.90%31.52M

56.95%-7.38M

90.48%-1.70M

-9.45%-13.87M

-140.80%-20.89M

-435.01%-17.15M

-49.92%-17.86M

4.50%-12.67M

91.22%51.19M

72.55%-3.21M

58.46%-11.91M

59.59%-13.27M

191.56%26.77M

48.16%-11.68M

-54.44%-28.68M

-69.02%-32.83M

-57.33%-29.24M

-18.93%-22.52M

-6.12%-18.57M

18.41%-19.42M

25.62%-18.59M

-6.88%-18.94M

-33.09%-17.50M

-369.38%-23.81M

-135.74%-24.99M

-69.33%-17.72M

-32.08%-13.15M

52.35%-5.07M

28.24%-10.60M

13.36%-10.46M

17.86%-9.96M

-49.28%-10.64M

-77.25%-14.77M

-62.97%-12.08M

---12.12M

---7.13M

---8.33M

---7.41M

优先股派息

----

--0.00

----

--0.00

--549.00K

----

-100.00%0.00

----

-9.26%833.00K

124.02%2.05M

--2.02M

--1.24M

--918.00K

--916.00K

归属于普通股东的净利润

48.05%-7.20M

250.90%31.52M

56.95%-7.38M

90.48%-1.70M

-9.45%-13.87M

-140.80%-20.89M

-435.01%-17.15M

-49.92%-17.86M

4.50%-12.67M

91.22%51.19M

72.55%-3.21M

58.46%-11.91M

59.59%-13.27M

191.56%26.77M

48.16%-11.68M

-54.44%-28.68M

-69.02%-32.83M

-57.33%-29.24M

-18.93%-22.52M

-6.12%-18.57M

18.41%-19.42M

25.62%-18.59M

-6.88%-18.94M

-33.09%-17.50M

-369.38%-23.81M

-135.74%-24.99M

-69.33%-17.72M

-32.08%-13.15M

52.35%-5.07M

28.24%-10.60M

13.36%-10.46M

17.86%-9.96M

-49.28%-10.64M

-77.25%-14.77M

-62.97%-12.08M

---12.12M

---7.13M

---8.33M

---7.41M

基本每股收益

49.78%-0.13

245.72%0.56

58.60%-0.13

90.83%-0.03

-5.79%-0.25

-139.65%-0.38

-421.05%-0.32

-46.08%-0.33

6.28%-0.24

76.19%0.97

81.31%-0.06

73.94%-0.23

74.92%-0.25

160.61%0.55

53.58%-0.33

-38.97%-0.87

-52.47%-1.01

-33.37%-0.90

18.82%-0.70

26.21%-0.63

45.75%-0.66

48.26%-0.68

9.08%-0.86

-13.96%-0.85

-313.31%-1.22

-119.58%-1.31

-58.55%-0.95

-7.48%-0.74

60.24%-0.29

41.93%-0.60

31.08%-0.60

20.60%-0.69

-44.38%-0.74

-71.43%-1.03

-62.97%-0.87

---0.87

---0.51

---0.60

---0.53

稀释每股收益

49.78%-0.13

220.05%0.46

58.60%-0.13

90.83%-0.03

-5.79%-0.25

-140.51%-0.38

-421.05%-0.32

-46.08%-0.33

6.28%-0.24

72.48%0.95

81.31%-0.06

73.94%-0.23

74.92%-0.25

160.61%0.55

53.58%-0.33

-38.97%-0.87

-52.47%-1.01

-33.37%-0.90

18.82%-0.70

26.21%-0.63

45.75%-0.66

48.26%-0.68

9.08%-0.86

-13.96%-0.85

-313.31%-1.22

-119.58%-1.31

-58.55%-0.95

-7.48%-0.74

60.24%-0.29

41.93%-0.60

31.08%-0.60

20.60%-0.69

-44.38%-0.74

-71.43%-1.03

-62.97%-0.87

---0.87

---0.51

---0.60

---0.53

每股派息

--0.00

货币单位

--USD

审计意见

----

常见问题

如何在 TradingKey 上查看 Spero Therapeutics Inc 的利润表？



先看总营收，再依次查看营收成本、毛利润、营业费用、营业利润、税前利润、净利润和每股收益（EPS）。营收反映公司的业务规模，而各项利润和利润率则体现公司能否有效地将营收转化为盈利。

季度利润表和年度利润表有什么区别？



季度利润表反映公司在一个为期三个月的财务季度内的经营表现，年度利润表则汇总整个财年的业绩。季度数据适合用于观察近期发展势头和季节性变化，年度数据则更适合评估长期增长、盈利能力和业务周期。

利润表页面中的同比是什么意思？



同比是指将某项财务指标与上年同期进行比较，例如将本季度营收与去年同一季度的营收进行对比。同比数据有助于投资者观察增长趋势，同时减少正常季节性变化对分析的影响。

分析 SPRO 股票时，哪些利润表指标最重要？



重要的指标包括营收增长、毛利润、毛利率、营业利润、营业利润率、净利润、每股收益、研发费用、销售及管理费用以及所得税费用。投资者通常会综合分析这些指标，以判断公司是否正在增长、有效控制成本并提升盈利能力。

Spero Therapeutics Inc 财年末的营收是多少？



Spero Therapeutics Inc 2025 财年营收为 66.80M，高于上一财年的47.98M。

Spero Therapeutics Inc 最近一个季度的营收是多少？



Spero Therapeutics Inc 最近一个季度的营收为 258.00K，同比增长 -95.61%。

Spero Therapeutics Inc 全年的净利润是多少？



Spero Therapeutics Inc 2025 财年净利润为 8.57M。

Spero Therapeutics Inc 上一季度的净利润是多少？



Spero Therapeutics Inc 最近一个季度的净利润为 -7.20M。

Spero Therapeutics Inc 年度营业利润是多少？



Spero Therapeutics Inc 2025 财年的营业利润为 7.16M。

每股收益与利润表有什么关系？



每股收益（EPS）通常以净利润除以流通在外的股份数量计算，用于衡量公司平均每股创造的利润。分析 EPS 时，还应结合股本变化、利润率、现金流和估值指标进行综合判断。